OVO biomanufacturing
The Coventry University and the University of Warwick spin-out company has secured funding from the Greater Manchester and Chester Life Sciences Fund (managed by Catapult Ventures) to develop digital solutions to improve the manufacturing efficiency for viral vaccines and gene therapies.